Profile data is unavailable for this security.
About the company
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
- Revenue in USD (TTM)39.80m
- Net income in USD-18.22m
- Incorporated2019
- Employees173.00
- LocationAlpha Teknova Inc2451 Bert DriveHOLLISTER 95023United StatesUSA
- Phone+1 (831) 637-1100
- Fax+1 (845) 818-3588
- Websitehttps://www.teknova.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QT Imaging Holdings Inc | 11.50m | -19.51m | 67.68m | 20.00 | -- | -- | -- | 5.89 | -2.09 | -2.09 | 1.27 | -0.939 | 1.20 | 1.34 | 6.57 | 574,821.50 | -204.52 | -- | -4,313.85 | -- | 50.81 | -- | -169.73 | -- | 0.4745 | -2.02 | 80.26 | -- | 11,987.88 | -- | -132.34 | -- | -- | -- |
| InspireMD Inc | 7.78m | -46.20m | 74.15m | 85.00 | -- | 1.14 | -- | 9.53 | -0.8396 | -0.8396 | 0.139 | 1.53 | 0.1207 | 1.93 | 4.46 | 91,517.65 | -71.65 | -60.63 | -83.34 | -71.77 | 24.91 | 20.76 | -593.89 | -377.98 | 6.17 | -- | 0.00 | -- | 12.96 | 13.50 | -60.70 | -- | 37.62 | -- |
| MaxCyte Inc | 34.42m | -45.63m | 74.68m | 114.00 | -- | 0.4142 | -- | 2.17 | -0.4298 | -0.4298 | 0.3243 | 1.69 | 0.149 | 0.7657 | 5.35 | 301,921.10 | -19.75 | -13.01 | -21.30 | -14.01 | 79.97 | 87.32 | -132.58 | -72.43 | 7.27 | -- | 0.00 | -- | -6.44 | 12.31 | -8.26 | -- | 5.37 | -- |
| DarioHealth Corp | 24.73m | -37.11m | 78.06m | 196.00 | -- | 1.04 | -- | 3.16 | -12.47 | -12.47 | 8.29 | 11.07 | 0.2173 | 2.22 | 6.51 | 126,183.70 | -37.17 | -63.89 | -42.41 | -75.30 | 56.86 | 34.31 | -171.09 | -262.34 | 4.02 | -69.69 | 0.2901 | -- | 32.86 | 29.04 | 35.47 | -- | 7.09 | -- |
| Xtant Medical Holdings Inc | 133.08m | 1.75m | 82.67m | 217.00 | 57.78 | 1.64 | 12.37 | 0.6212 | 0.0102 | 0.0102 | 0.9158 | 0.3599 | 1.30 | 1.22 | 5.78 | 613,285.70 | 1.71 | -11.38 | 2.57 | -16.17 | 62.02 | 59.37 | 1.32 | -9.64 | 1.06 | 1.57 | 0.3635 | -- | 28.44 | 12.64 | -2,592.27 | -- | 36.16 | -- |
| Neuronetics Inc | 129.87m | -44.50m | 97.93m | 716.00 | -- | 3.58 | -- | 0.7541 | -0.8344 | -0.8344 | 2.24 | 0.3997 | 1.18 | 13.87 | 7.31 | 181,386.90 | -40.63 | -29.61 | -52.56 | -36.96 | 50.43 | 74.98 | -34.35 | -53.71 | 2.09 | -4.31 | 0.6768 | -- | 4.96 | 3.63 | -44.78 | -- | 12.51 | -- |
| Vivani Medical Inc | 0.00 | -26.03m | 102.32m | 42.00 | -- | 59.21 | -- | -- | -0.4417 | -0.4417 | 0.00 | 0.0213 | 0.00 | -- | -- | 0.00 | -76.61 | -43.12 | -94.91 | -49.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 8.44 | -- | 2.43 | -- |
| Alpha Teknova Inc | 39.80m | -18.22m | 106.52m | 173.00 | -- | 1.47 | -- | 2.68 | -0.3409 | -0.3409 | 0.7446 | 1.36 | 0.3435 | 3.77 | 8.17 | 230,063.60 | -15.73 | -19.57 | -16.94 | -20.97 | 30.97 | 38.24 | -45.78 | -63.70 | 4.27 | -28.65 | 0.1525 | -- | 2.89 | 12.68 | 27.28 | -- | -16.96 | -- |
| Picard Medical Inc | 4.77m | -33.80m | 106.87m | 75.00 | -- | 13.41 | -- | 22.39 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Hyperfine Inc | 10.59m | -40.05m | 110.70m | 111.00 | -- | 3.29 | -- | 10.45 | -0.5243 | -0.5243 | 0.1385 | 0.3339 | 0.191 | 0.8859 | 1.81 | 95,414.41 | -72.23 | -45.05 | -88.25 | -48.86 | 46.12 | 30.47 | -378.17 | -757.55 | 3.06 | -- | 0.00 | -- | 16.84 | -- | 7.95 | -- | 9.44 | -- |
| Treace Medical Concepts Inc | 218.88m | -50.11m | 116.60m | 477.00 | -- | 1.31 | -- | 0.5327 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| CVRx Inc | 56.65m | -53.31m | 124.72m | 223.00 | -- | 3.17 | -- | 2.20 | -2.04 | -2.04 | 2.17 | 1.49 | 0.4756 | 0.6837 | 5.68 | 254,040.40 | -44.76 | -39.12 | -49.79 | -42.10 | 85.33 | 82.74 | -94.10 | -130.77 | 6.72 | -8.80 | 0.5574 | -- | 10.45 | 56.40 | 11.10 | -- | 13.27 | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 127.95m | 181.00 | 11.91 | 3.14 | 10.29 | 1.82 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Fonar Corp | 105.43m | 6.99m | 135.73m | 535.00 | 17.80 | 0.6946 | 9.67 | 1.29 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LifeMD Inc | 252.34m | -7.71m | 137.19m | 304.00 | -- | 101.02 | 27.78 | 0.5437 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| LENSAR Inc | 59.14m | -51.52m | 139.27m | 140.00 | -- | -- | -- | 2.35 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
Data as of Feb 17 2026. Currency figures normalised to Alpha Teknova Inc's reporting currency: US Dollar USD
9.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Roubaix Capital LLCas of 31 Dec 2025 | 998.53k | 1.87% |
| Balyasny Asset Management LPas of 30 Sep 2025 | 987.23k | 1.84% |
| UBS Securities LLCas of 31 Dec 2025 | 734.89k | 1.37% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 633.34k | 1.18% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 514.19k | 0.96% |
| Conestoga Capital Advisors LLCas of 31 Dec 2025 | 317.08k | 0.59% |
| Royce & Associates LPas of 31 Dec 2025 | 293.58k | 0.55% |
| Geode Capital Management LLCas of 31 Dec 2025 | 287.43k | 0.54% |
| Bank of America, NA (Private Banking)as of 30 Sep 2025 | 224.43k | 0.42% |
| Massar Capital Management LPas of 30 Sep 2025 | 200.00k | 0.37% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
